87 related articles for article (PubMed ID: 20148873)
21. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination.
Lappe-Siefke C; Goebbels S; Gravel M; Nicksch E; Lee J; Braun PE; Griffiths IR; Nave KA
Nat Genet; 2003 Mar; 33(3):366-74. PubMed ID: 12590258
[TBL] [Abstract][Full Text] [Related]
22. In vitro myelination by oligodendrocyte precursor cells transfected with the neurotrophin-3 gene.
Rubio N; Rodriguez R; Arevalo MA
Glia; 2004 Jul; 47(1):78-87. PubMed ID: 15139015
[TBL] [Abstract][Full Text] [Related]
23. Developmental expression of neural cell type-specific mRNA markers in the myelin-deficient mutant rat brain: inhibition of oligodendrocyte differentiation.
Kumar S; Gordon MN; Espinosa de los Monteros MA; de Vellis J
J Neurosci Res; 1988; 21(2-4):268-74. PubMed ID: 2464079
[TBL] [Abstract][Full Text] [Related]
24. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.
Barley K; Dracheva S; Byne W
Schizophr Res; 2009 Jul; 112(1-3):54-64. PubMed ID: 19447584
[TBL] [Abstract][Full Text] [Related]
25. [Determination of myelin marker enzymes in the blood serum in peripheral nervous system diseases].
Savchenko IuN
Biull Eksp Biol Med; 1982 Apr; 93(4):34-5. PubMed ID: 6282360
[TBL] [Abstract][Full Text] [Related]
26. Myelin: not just a conduit for conduction.
Popko B
Nat Genet; 2003 Mar; 33(3):327-8. PubMed ID: 12610543
[No Abstract] [Full Text] [Related]
27. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain.
Paintlia MK; Paintlia AS; Barbosa E; Singh I; Singh AK
J Neurosci Res; 2004 Nov; 78(3):347-61. PubMed ID: 15389835
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic role of determination of blood 2', 3'-cyclic nucleotide-3-phosphohydrolase activity].
Khokhlov AP; Savchenko IuN; Mamedov LA
Lab Delo; 1982; (4):210-2. PubMed ID: 6177902
[No Abstract] [Full Text] [Related]
29. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.
Wakabayashi Y; Uchida S; Funato H; Matsubara T; Watanuki T; Otsuki K; Fujimoto M; Nishida A; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1199-205. PubMed ID: 18430502
[TBL] [Abstract][Full Text] [Related]
30. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
Uezato A; Meador-Woodruff JH; McCullumsmith RE
Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
[TBL] [Abstract][Full Text] [Related]
31. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients.
Dracheva S; Davis KL; Chin B; Woo DA; Schmeidler J; Haroutunian V
Neurobiol Dis; 2006 Mar; 21(3):531-40. PubMed ID: 16213148
[TBL] [Abstract][Full Text] [Related]
32. The 2',3'-cyclic nucleotide 3'-phosphodiesterase and oligodendrocyte lineage transcription factor 2 genes do not appear to be associated with schizophrenia in the Japanese population.
Usui H; Takahashi N; Saito S; Ishihara R; Aoyama N; Ikeda M; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Yoshida K; Iwata N; Inada T; Ozaki N
Schizophr Res; 2006 Dec; 88(1-3):245-50. PubMed ID: 17010574
[TBL] [Abstract][Full Text] [Related]
33. The neurosteroid progesterone increases the expression of myelin proteins (MBP and CNPase) in rat oligodendrocytes in primary culture.
Jung-Testas I; Schumacher M; Robel P; Baulieu EE
Cell Mol Neurobiol; 1996 Jun; 16(3):439-43. PubMed ID: 8818411
[No Abstract] [Full Text] [Related]
34. Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
Davis KL; Haroutunian V
Lancet; 2003 Sep; 362(9386):758. PubMed ID: 13678867
[No Abstract] [Full Text] [Related]
35. Structure of the myelin membrane enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: evidence for two human mRNAs.
Douglas AJ; Thompson RJ
Biochem Soc Trans; 1993 May; 21(2):295-7. PubMed ID: 8395421
[No Abstract] [Full Text] [Related]
36. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder.
Chambers JS; Perrone-Bizzozero NI
Neurochem Res; 2004 Dec; 29(12):2293-302. PubMed ID: 15672553
[TBL] [Abstract][Full Text] [Related]
37. Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia.
Haroutunian V; Davis KL
Int J Neuropsychopharmacol; 2007 Aug; 10(4):499-502. PubMed ID: 17583597
[TBL] [Abstract][Full Text] [Related]
38. Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.
Bernstein HG; Jauch E; Dobrowolny H; Mawrin C; Steiner J; Bogerts B
Eur Arch Psychiatry Clin Neurosci; 2016 Sep; 266(6):495-504. PubMed ID: 26315603
[TBL] [Abstract][Full Text] [Related]
39. Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia.
Tkachev D; Mimmack ML; Huffaker SJ; Ryan M; Bahn S
Int J Neuropsychopharmacol; 2007 Aug; 10(4):557-63. PubMed ID: 17291371
[TBL] [Abstract][Full Text] [Related]
40. Oligodendrocyte pathophysiology: a new view of schizophrenia.
Segal D; Koschnick JR; Slegers LH; Hof PR
Int J Neuropsychopharmacol; 2007 Aug; 10(4):503-11. PubMed ID: 17291369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
